Showing results (491-500 of 512) with videos related to
Sort By:
Pageof 52
BJU International|November 18, 2003
Expression and cellular localization of Na,K-ATPase isoforms in the rat ventral prostateA Mobasheri, N B Pestov, S Papanicolaou, et al.Proceedings of the National Academy of Sciences of the United States of America|August 2, 1994
Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoidJ J Yunis, N Mobini, E J Yunis, et al.Histopathology|September 21, 2007
Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcomeD M Berney, G Fisher, M W Kattan, et al.Cornea|January 1, 1989
Factors influencing predilection and outcome in bacterial keratitisO G Gudmundsson, L D Ormerod, K R Kenyon, et al.American Journal of Ophthalmology|May 1, 1997
Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trialR B Nussenblatt, I Gery, H L Weiner, et al.Oncology Reports|January 1, 2010
Elevated expression of Ki-67 identifies aggressive prostate cancers but does not distinguish BRCA1 or BRCA2 mutation carriersA V Mitra, C Jameson, Y Barbachano, et al.Prostate Cancer and Prostatic Diseases|November 21, 2012
Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancerN Vasiljević, A S Ahmad, C Beesley, et al.British Journal of Cancer|March 19, 2009
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group studyD M Berney, A Gopalan, S Kudahetti, et al.Liver|August 1, 1997
In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liverS D Taylor-Robinson, J Sargentoni, J D Bell, et al.British Journal of Cancer|February 25, 2012
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohortJ Cuzick, D M Berney, G Fisher, et al.Pageof 52